NCT00636870View on ClinicalTrials.gov

Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for Desloratadine

PHASE4CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

February 28, 2003

Study Completion Date

January 31, 2004

Conditions
Allergic Rhinitis
Interventions
DRUG

Fexofenadine

Trial Locations (1)

08807

Sanofi-Aventis, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY